SCHEMBL16270517

SCHEMBL16270517

O=C=Nc1ccc(OC(=O)COCCOC(=O)c2ccc(N=C=O)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 9/20 0.39
▸ ACR P10323 2/20 0.39
▸ F2 P00734 6/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ SLC22A2 O15244 2/20 0.38
▸ TMPRSS2 O15393 2/20 0.38
▸ HPN P05981 2/20 0.38
▸ KCNH2 Q12809 2/20 0.38
▸ SLC47A2 Q86VL8 2/20 0.38
▸ SLC47A1 Q96FL8 2/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ F10 P00742 1/20 0.38
▸ PLG P00747 1/20 0.38
▸ F12 P00748 1/20 0.38
▸ PLAU P00749 1/20 0.38
▸ PLAT P00750 1/20 0.38
▸ KLKB1 P03952 1/20 0.38
▸ CHRM2 P08172 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12152614 0.89 PRSS1 (0.41) PRSS1CYP1A2CYP2D6SLC6A2PRSS2
SCHEMBL15708348 0.89 CYP3A4 (0.42) PRSS1F2KMT2ACYP1A2PRSS2
SCHEMBL16574509 0.88 SERPINE1 (0.42) PRSS1CYP1A2CYP2D6SLC6A2PRSS2
SCHEMBL16270514 0.88 PRSS1 (0.43) PRSS1ACRF2KMT2ASLC22A2
SCHEMBL9420499 0.85 SERPINE1 (0.49) PRSS1CYP1A2CYP2D6SLC6A2PRSS2
SCHEMBL9420514 0.85 SERPINE1 (0.49) PRSS1CYP1A2CYP2D6SLC6A2PRSS2
SCHEMBL9420474 0.85 SERPINE1 (0.49) PRSS1CYP1A2CYP2D6SLC6A2PRSS2
SCHEMBL11956787 0.84 PRSS1 (0.34) PRSS1ACRKMT2ACYP1A2CYP2D6
SCHEMBL11925961 0.84 TMPRSS15 (0.35) PRSS1PRSS2PRSS3CTSL
SCHEMBL16270525 0.84 GAA (0.39) PRSS1ACRMAPTNPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160023997-A1 ABSORBABLE POLYURETHANES AND METHODS OF USE THEREOF BEZWADA BIOMEDICAL LLC (US) 2016-01-28 — — US disclosed
US-20150080301-A1 ABSORBABLE POLYURETHANES AND METHODS OF USE THEREOF BEZWADA BIOMEDICAL LLC (US) 2015-03-19 — — US disclosed
US-8901347-B1 Absorbable polyurethanes and methods of use thereof BEZWADA BIOMEDICAL, LLC (US) 2014-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150080301-A1 ABSORBABLE POLYURETHANES AND METHODS OF USE THEREOF HPGDS, ITGAM, P4HTM PRSS1 2171/4885ACR 4390/4885F2 33/4885
US-20160023997-A1 ABSORBABLE POLYURETHANES AND METHODS OF USE THEREOF HPGDS, ITGAM, P4HTM PRSS1 2171/4885ACR 4390/4885F2 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback